Epilepsy
Created:   10/12/2010
Contains:  98 items

Creator: Jamie Talan
Duration: 10:50
Orrin Devinsky, MD, professor of neurology, neurosurgery, and psychiatry, and director of the Comprehensive Epilepsy Center at New York University Langone Medical Center, and his colleagues surveyed neurologists in the United States and Canada about their perspectives on discussing sudden unexplained death in epilepsy (SUDEP) with their patients or their families. They also surveyed patients and 574 caregivers, virtually all of whom said that they wanted to know about SUDEP. Here, he discusses the results of the surveys presented at the annual meeting of the American Epilepsy Society in December and what neurologists can do to frame the discussion about SUDEP in a more positive way. See the Jan. 3 issue of Neurology Today.
Creator: Olga Rukovets
Duration: 6:54
Neurology Today 
Christopher M. DeGiorgio, MD, professor of neurology at the University of California-Los Angeles, and vice president of NeuroSigma, discusses the benefits of external trigeminal nerve stimulation, and how it could affect epilepsy treatment for patients with drug-resistant epilepsy. For the full article, see the Feb. 21 issue of Neurology Today.
Creator: Neurology Today
Duration: 2:02
Journal: Neurology Today
A team of neurosurgeons reported at the AAN annual meeting that minimally invasive stereotactic laser ablation could be a safer alternative than traditional surgery for removing epileptogenic hypothalamic hamartomas. In a video discussion, Jacqueline A. French, MD — professor of neurology at New York University Comprehensive Epilepsy Center, president of the American Epilepsy Society, and a member of the Neurology Today editorial advisory board — discusses why this is a development that clinicians may welcome, but offers caveats for future research that is needed before the surgery should be considered.
Creator: Neurology Today
Duration: 2:09
Journal: Neurology Today
From the AAN annual meeting: Investigators pored through eight years of medical records — seven years before the diagnosis of psychogenic nonepileptic seizures (PNES) was made and one year after — and found that the patients’ use of hospitals and clinics decreased dramatically after they were given the proper diagnosis. Watch here as Neurology Today editorial advisory board member Jacqueline A. French, MD, professor of neurology at New York University Comprehensive Epilepsy Center and president of the American Epilepsy Society, discusses what this can mean for clinicians seeing patients with PNES.